FDA Warning Letter — Chongqing Lummy Pharmaceutical Co. Ltd.
The FDA took a Warning Letter action against Chongqing Lummy Pharmaceutical Co. Ltd. on June 22, 2016 (Chongqing, China). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Chongqing Lummy Pharmaceutical Co. Ltd.
- Date
- June 22, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Center
- CDER
- Location
- Chongqing (China)